Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Talaris Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues0.00.00.013.4
            Revenue growth  -100.0% 
Cost of goods sold0.00.00.026.7
Gross profit0.00.00.0-13.4
            Gross margin   -100.0%
Selling, general and administrative76.547.522.7 
General and administrative   5.0
EBIT0.00.00.0-18.4
            EBIT margin   -137.5%
Pre-tax income-73.9-47.8-22.7-18.2
Income taxes0.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%
Net income-73.9-47.8-22.70.0
            Net margin   -0.1%
 
Diluted EPS($1.79)($1.64)($3.40)($2.84)
Shares outstanding (diluted)41.229.16.70.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy